Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland

Phase III trials have demonstrated the efficacy of human papillomavirus (HPV) vaccines in preventing transient and persistent high-risk (hr) HPV infection and precancerous lesions. A mathematical model of HPV type 16 infection and progression to cervical cancer, parameterised to represent the infect...

Descripción completa

Detalles Bibliográficos
Autores principales: French, K M, Barnabas, R V, Lehtinen, M, Kontula, O, Pukkala, E, Dillner, J, Garnett, G P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360033/
https://www.ncbi.nlm.nih.gov/pubmed/17245341
http://dx.doi.org/10.1038/sj.bjc.6603575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360033/
https://www.ncbi.nlm.nih.gov/pubmed/17245341
http://dx.doi.org/10.1038/sj.bjc.6603575

Ejemplares similares